Understanding Evaluation of Patient Information Sheets of Two Multiple Sclerosis Studies Through User Testing Method in a Randomized, Open Label, Crossover Design

Status unknownNot a drug-phase studyMS (type not specified)NCT03155334

What it found

No results found

We found no results in the registry or in papers.

What was tested

Treatment tested

  • PIS User Testing

What it measured

Main measures

  • percentage of found and understood-if-found items

    1 day

Other measures (1)

  • understanding of the text expressed by subject

    1 day

Who could take part

MS (type not specified) · 18 and over

Show the full criteria

Inclusion criteria

Inclusion Criteria: PwMS (60%) and Caregivers (40%): for PwMS: * 18 years or older; * MS diagnosis according to McDonald criteria; * Informed consent to the present study for caregivers: * 18 years or older; * in being a person who takes care of a PwMS; * Informed consent to the present study

Exclusion criteria

- not having taken part in one of the following trials evaluated in the present study: A) Observational Study of the Prevalence of CCSVI in Multiple Sclerosis and in Other Neurodegenerative Diseases (PIS-A); B) BRAin VEnous DRainage Exploited Against Multiple Sclerosis (PIS-B).

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

The purpose of this randomized, open label, crossover, single site study is to compare the PISs of two Multiple Sclerosis clinical trials to elucidate potential aspects of the given written information that could impact on the smooth running of the studies.

Papers

Loading reviews and guidelines…

History

    1. Started

      Jan 2017

    2. Main results due

      Feb 2018

    3. Finished

      Dec 2018

    Assembled by software from public sources.